AACR-NCI-EORTC Poster A044
Precision Medicine Platform to Predict Clinical Responses for Ovarian Cancer

A Precision Medicine Platform To Predict The Clinical Response To Chemo And Immunotherapy For Epithelial Ovarian Cancer

Discovery of Precision Oncology Drugs

NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com

Predictive Precision Medicine Platform for Ovarian Cancer

The poster presents a biomarker discovery platform using ascites of ovarian cancer patients. The aim is to develop a Precision Medicine Platform to predict the clinical response to chemo- and immunotherapy for epithelial ovarian cancer patients.

Access Cancer Cell Lines, Proliferation Assays and Bioinformatics Analysis to Find Patient Stratification Markers

ONCOLINES®

Apply Combination Studies
to Identify
Novel Synergies

SYNERGYFINDER™

Use Cell-Based Assays
to Determine
Mechanism of Action

MECHANISTIC CELL BIOLOGY

Information Needed?

Please contact us for more information